IP Library Granted Patent US 8,609,414
Granted Patent B2
US 8,609,414 · App. 13/167,493 · Granted Dec 17, 2013

Isolation and growth of stem cells from hemangiomas

Inventors: Yupo Ma (Las Vegas, NV); Louis M. Fink (Las Vegas, NV); David C. Ward (Las Vegas, NV); Milton Waner (New York, NY)
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,609,414
App. No.
13/167,493
Granted
Dec 17, 2013
Kind
B2
Abstract

The present invention describes stem cells and progenitor cells derived from hemangiomas, including testing of angiogenic inhibitors using these cells. The invention as described is useful in providing a process to culture and propagate hemangioma stem cells and generate xenograft models to develop treatments for infantile hemangiomas and other types of vascular lesions.

Claims (6)

1. A method of isolating stem cells comprising:

a) isolating cells from hemangioma tissue;

b) culturing the cells of step (a) in serum free media and fibroblast growth factor in a low attachment plate until tumor spheres are formed;

c) isolating cells from the tumor spheres; and

d) culturing the isolated cells of step (c) in serum free media, wherein the isolated stem cells are capable of differentiating into endothelial-like tissue when contacted with VEGF.

2. The method of claim 1 , wherein the stem cell expresses SALL4.

Assignments (1)
CONFIRMATORY LICENSE Recorded Jan 30, 2013
From: NEVADA CANCER INSTITUTE FOUNDATION
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 029721/0985 →
Continuity (4)
Continuation 12130656 · May 30, 2008
Continuation In Part 11809871 · Jun 1, 2007
Provisional Application 61050131 · May 2, 2008
Related Publication 20120117672A1 · May 10, 2012